146 related articles for article (PubMed ID: 8630511)
1. Von Hippel-Lindau tumor suppressor protein and transcription elongation: new insights into regulation of gene expression.
Bertherat J
Eur J Endocrinol; 1996 Feb; 134(2):157, 159. PubMed ID: 8630511
[No Abstract] [Full Text] [Related]
2. The molecular basis of von Hippel-Lindau disease.
Iliopoulos O; Kaelin WG
Mol Med; 1997 May; 3(5):289-93. PubMed ID: 9205944
[No Abstract] [Full Text] [Related]
3. The von Hippel-Lindau tumour suppressor protein: new perspectives.
Ohh M; Kaelin WG
Mol Med Today; 1999 Jun; 5(6):257-63. PubMed ID: 10366821
[TBL] [Abstract][Full Text] [Related]
4. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C.
Kibel A; Iliopoulos O; DeCaprio JA; Kaelin WG
Science; 1995 Sep; 269(5229):1444-6. PubMed ID: 7660130
[TBL] [Abstract][Full Text] [Related]
5. Formation of the VHL-elongin BC tumor suppressor complex is mediated by the chaperonin TRiC.
Feldman DE; Thulasiraman V; Ferreyra RG; Frydman J
Mol Cell; 1999 Dec; 4(6):1051-61. PubMed ID: 10635329
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transcription elongation by the VHL tumor suppressor protein.
Duan DR; Pause A; Burgess WH; Aso T; Chen DY; Garrett KP; Conaway RC; Conaway JW; Linehan WM; Klausner RD
Science; 1995 Sep; 269(5229):1402-6. PubMed ID: 7660122
[TBL] [Abstract][Full Text] [Related]
7. Von Hippel-Lindau disease: how does one gene cause multiple tumors?
Roach ES
Neurology; 1999 Jul; 53(1):7-8. PubMed ID: 10408528
[No Abstract] [Full Text] [Related]
8. The von Hippel-Lindau tumor suppressor protein.
Ivan M; Kaelin WG
Curr Opin Genet Dev; 2001 Feb; 11(1):27-34. PubMed ID: 11163147
[TBL] [Abstract][Full Text] [Related]
9. Von Hippel-Lindau (VHL) gene analysis in Italian families with VHL disease.
Montera M; Bellone E; Ajmar F; Mandich P
Contrib Nephrol; 1997; 122():109-11. PubMed ID: 9399050
[No Abstract] [Full Text] [Related]
10. The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis.
Barry RE; Krek W
Trends Mol Med; 2004 Sep; 10(9):466-72. PubMed ID: 15350900
[No Abstract] [Full Text] [Related]
11. The von Hippel-Lindau tumor-suppressor gene product forms a stable complex with human CUL-2, a member of the Cdc53 family of proteins.
Pause A; Lee S; Worrell RA; Chen DY; Burgess WH; Linehan WM; Klausner RD
Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2156-61. PubMed ID: 9122164
[TBL] [Abstract][Full Text] [Related]
12. [File no. 41. VHL (von Hippel-Lindau). Tumor suppressor gene].
Soussi T
Bull Cancer; 2000 Nov; 87(11):771-2. PubMed ID: 11190567
[No Abstract] [Full Text] [Related]
13. Tumor suppression and transcription elongation: the dire consequences of changing partners.
Krumm A; Groudine M
Science; 1995 Sep; 269(5229):1400-1. PubMed ID: 7660121
[No Abstract] [Full Text] [Related]
14. Interaction of von Hippel-Lindau tumor suppressor gene product with elongin.
Pause A; Aso T; Linehan WM; Conaway JW; Conaway RC; Klausner RD
Methods Enzymol; 1996; 274():436-41. PubMed ID: 8902823
[No Abstract] [Full Text] [Related]
15. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Vortmeyer AO; Choo D; Pack S; Oldfield E; Zhuang Z
Neurology; 2000 Aug; 55(3):460. PubMed ID: 10932304
[No Abstract] [Full Text] [Related]
16. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin, tumours and the von Hippel-Lindau gene: towards identification of mechanisms and dysfunction of oxygen sensing.
Wiesener MS; Eckardt KU
Nephrol Dial Transplant; 2002 Mar; 17(3):356-9. PubMed ID: 11865075
[No Abstract] [Full Text] [Related]
18. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis.
Richards FM; Schofield PN; Fleming S; Maher ER
Hum Mol Genet; 1996 May; 5(5):639-44. PubMed ID: 8733131
[TBL] [Abstract][Full Text] [Related]
19. Von Hippel-Lindau syndrome: hereditary cancer arising from inherited mutations of the VHL tumor suppressor gene.
Humphrey JS; Klausner RD; Linehan WM
Cancer Treat Res; 1996; 88():13-39. PubMed ID: 9239471
[No Abstract] [Full Text] [Related]
20. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insight into basic mechanisms of carcinogenesis.
Decker HJ; Weidt EJ; Brieger J
Cancer Genet Cytogenet; 1997 Jan; 93(1):74-83. PubMed ID: 9062583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]